Susan M. Webb

TL;DR: Verbal and visual memory is worse in CS patients than controls, even after biochemical cure, and brain gray matter volumes were decreased in CS compared with controls, indicating brain atrophy, whereas subcortical gray matter was reduced only in the 12 patients with severe memory impairment.

TL;DR: Quality of life (QoL) is impaired in acromegaly, especially in active disease, and QoL is associated with the presence of musculoskeletal pain, headache, having required treatment with radiotherapy, being older, of female gender, with a longer disease duration, coexisting diabetes mellitus, a higher BMI or becoming GH deficient after treatment for acromEGaly.

TL;DR: The most effective option for the medical treatment of patients with acromegaly is the use of somatostatin analogues and efficacy of octreotide LAR and lanreotide SR in acromegalic patients is compared.

TL;DR: Assessment of glucose tolerance in consecutive patients with ‘nonfunctioning’ adrenal adenomas and the influence of the status of the hypothalamo–pituitary–adrenal axis (HPAA) on carbohydrate tolerance are studied.

TL;DR: Long-acting pasireotide is an efficacious treatment option for some patients with Cushing's disease who have persistent or recurrent disease after initial surgery or are not surgical candidates, and provides a convenient monthly administration schedule.